Reinventing pharma
tHrough cannabis innovation
Motagon’s aim is to bring cutting edge medical cannabis products and expertise, both in Europe and worldwide.




About
Medical Cannabis
The therapeutic properties of the cannabis plant have been long known throught history, and used in traditional medicine. Recent research is starting to clarify the underlying mechanisms and fortify the evidence of its many beneficial effects, enabling it to slowly reclaim its spot in contemporary therapeutic approaches.


About motagon
Motagon is one of the key players in the CEE cannabis sector, with the aspiration to expand presence throughout Europe. Founded as a joint venture by the Canadian M&A advisory firm KOMAND Consulting and the German healthcare business development consultancy Jelinda, Motagon brings cannabis innovation and knowledge to European markets.




Medical Cannabis for
Patients
Are you an active medical cannabis user or are interested in becoming one? Explore more about the current research findings, therapeutic applications, advice for new patients and treatment accessibility.

Company
portfolio and
services
Are you a company or individual interested in supply, distribution or other business arrangements? Explore more about Motagon’s product portfolio and services, quality, licenses and certifications.
Medical Cannabis for
Health Care
Professionals
Are you a health care professional interested in contemporary research on medical cannabis or eager to find out more about Motagon’s products and their specific properties? Explore in this section.

Motagon Cannabis
Products

Motagon offers a range of medical cannabis products, including EU-GMP cannabis flowers, full-spectrum oils (extracts) and advanced product forms, both EU manufactured and internationally sourced.
Quality
Motagon adheres to strict quality standards in all of our operations. The quality management systems at Motagon are acknowledged by Czech authorities, which certified Motagon with GMP, GDP and Narcotics handling licenses.
News & Blog
Motagon introduces GG4 medical cannabis to the Czech market
Motagon Cannabis, a subsidiary of international pharma company HEATON Group a.s., brings GG4 (Gorilla Glue 4), a high-THC medical cannabis flower,...
Cannabis treatment and the endocannabinoid system: Everything patients need to know
Cannabis treatment and the endocannabinoid system: Everything patients need to knowThe endocannabinoid system (ECS) is a receptor system that has a...
Media
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Czech market receives Motagon’s Gorilla Glue 4 cannabis for patients
Motagon says the import is a unique medical cannabis frontier with immense potential.


